Literature DB >> 11958559

Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.

G G Gibson1, N J Plant, K E Swales, A Ayrton, W El-Sankary.   

Abstract

1. The importance of CYP3A enzymes in drug metabolism and toxicology has yielded a wealth of information on the structure, function and regulation of this subfamily and recent research emphasis has been placed on the human forms, namely CYP3A4, CYP3A5, CYP3A7 and CYP3A43. 2. The current review will focus on the receptor-dependency of CYP3A regulation and includes consideration of the regulatory roles of the glucocorticoid (GR), pregnane X (PXR) and constitutive androstane (CAR) receptors. 3. Emphasis has been placed on the topics of expression and substrate specificity, assessment of induction, species differences in induction, CYP3A promoter sequences and regulation of gene expression, structural and functional aspects of receptor-mediated, CYP3A gene activation, receptor variants and interindividual variation in human CYP3A expression, the latter encompassing environmental, physiological and genetic aspects. 4. An outline of future research needs will be discussed in the context of receptor-mediated molecular mechanisms of CYP3A gene regulation and the impact on interindividual variations in CYP3A expression. 5. Taken collectively, this review highlights the importance of understanding the molecular mechanisms of CYP3A induction as a means of rationalizing human responses to many clinically used drugs, in addition to providing a mechanistically coherent platform to understand and predict interindividual variations in response and drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958559     DOI: 10.1080/00498250110102674

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  41 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

2.  Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.

Authors:  Al-Motassem Yousef; Nailya R Bulatova; William Newman; Nancy Hakooz; Said Ismail; Hisham Qusa; Farah Zahran; Nidaa Anwar Ababneh; Farah Hasan; Imad Zaloom; Ghada Khayat; Rawan Al-Zmili; Randa Naffa; Ola Al-Diab
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

3.  Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans.

Authors:  Kajsa P Persson; Susanne Ekehed; Charlotta Otter; E S Mareike Lutz; Jane McPheat; Collen M Masimirembwa; Tommy B Andersson
Journal:  Pharm Res       Date:  2006-11-22       Impact factor: 4.200

4.  Identification of regulatory sites in the human PXR (NR1I2) promoter region.

Authors:  Kouichi Kurose; Shinobu Ikeda; Satoru Koyano; Masahiro Tohkin; Ryuichi Hasegawa; Jun-ichi Sawada
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 5.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Cytochromes P450, induction and cholesterol--what are the connections?

Authors:  Olavi Pelkonen; Jukka Hakkola
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

7.  The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans.

Authors:  Patrick J Roberts; Kristan D Rollins; Angela D M Kashuba; Mary F Paine; Andrew C Nelsen; Eric E Williams; Cassandra Moran; Jatinder K Lamba; Erin G Schuetz; Roy L Hawke
Journal:  Drug Metab Dispos       Date:  2008-05-19       Impact factor: 3.922

8.  An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity.

Authors:  Yuki Kondo; Takahiro Iwao; Katsunori Nakamura; Takamitsu Sasaki; Shogo Takahashi; Noboru Kamada; Tsutomu Matsubara; Frank J Gonzalez; Hidenori Akutsu; Yoshitaka Miyagawa; Hajime Okita; Nobutaka Kiyokawa; Masashi Toyoda; Akihiro Umezawa; Kiyoshi Nagata; Tamihide Matsunaga; Shigeru Ohmori
Journal:  Drug Metab Pharmacokinet       Date:  2013-12-10       Impact factor: 3.614

9.  Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia.

Authors:  Caroline Fradette; Patrick du Souich
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

10.  Single nucleotide polymorphism of CYP3A4 intron 2 and its influence on CYP3A4 mRNA expression and liver enzymatic activity in human liver.

Authors:  Min Huang; Han-Ming Wang; Yu Guo; Jie Ping; Man Chen; Dan Xu; Hui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.